We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,200.60
Bid: 1,197.40
Ask: 1,198.00
Change: 9.80 (0.82%)
Spread: 0.60 (0.05%)
Open: 1,202.60
High: 1,215.20
Low: 1,195.80
Yest. Close: 1,190.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET CLOSE: UK Shares Dragged Down By Commodity Weakness

1 Jun 16 16:07

How Wellcome and Gates charities profit from helping biotech

* Wellcome firm gets approval for cancer imaging agent * First product from Wellcome Trust in two decades * Follows $80 mln biotech windfall for Gates foundation By Ben Hirschler LONDON, May 30 (Reuters) - The Wellcome Trust medical charity is to profit from U.S. approval

30 May 16 07:25

New incentives needed to develop antibiotics to fight superbugs

(Repeats May 27 story with no changes) By Bill Berkrot NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial

29 May 16 11:00

New incentives needed to develop antibiotics to fight superbugs

By Bill Berkrot NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the inves

27 May 16 23:52

CORRECTED-UPDATE 3-U.S. sees first case of bacteria resistant to last-resort antibiotic

(Corrects headline, first and third paragraphs to show bacteria is resistant to last-resort antibiotic colistin, not all antibiotics) By Ransdell Pierson and Bill Berkrot May 26 (Reuters) - U.S. health officials on Thursday reported the first case in the country of a patient with an i

27 May 16 16:30

GSK gets EU approval for first gene therapy for children

LONDON, May 27 (Reuters) - The world's first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering technology to fix faulty genes. Called Strimvelis, it is designed for a t

27 May 16 15:09

Glaxo's Strimvelix Gene Therapy Gets European Marketing Authorisation

27 May 16 14:56

UPDATE 1-G7 told to act on antibiotics as dreaded superbug hits U.S.

* Cameron urges G7 to back reward system for new drugs * U.S. sees first case of resistance to last-resort drug * Antimicrobial resistance moving up political agenda (Adds details on problem in U.S., China and Europe) By Kylie MacLellan and Ben Hirschler ISE-SHIMA, Japan

27 May 16 08:30

China regulator to launch drug pricing probe in June

SHANGHAI, May 27 (Reuters) - China will carry out wide-ranging pricing inspections on drug firms, hospitals and procurement bodies from June 1, the country's top watchdog said on Friday, extending a tough cost-cutting campaign to reduce the price of healthcare. The National Development and

27 May 16 02:42

UPDATE 3-U.S. sees first case of bacteria resistant to all antibiotics

(Adds details on Pennsylvania patient, paragraph 6) By Ransdell Pierson and Bill Berkrot May 26 (Reuters) - U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the

27 May 16 00:32

UPDATE 2-U.S. sees first case of bacteria resistant to all antibiotics

(Adds comments from CDC chief, shortage of research on superbugs) By Ransdell Pierson and Bill Berkrot May 26 (Reuters) - U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave con

26 May 16 23:47

UPDATE 1-Novartis willing to sell Roche stake without demanding premium - CEO

(Releads with CEO comments on Roche stake) ZURICH, May 25 (Reuters) - Swiss drugmaker Novartis is ready to sell its near $14 billion stake in rival Roche without demanding a premium, Chief Executive Joe Jimenez said on Wednesday. Novartis has been discussing options with banks for s

25 May 16 09:32

GlaxoSmithKline Reports Long-Term Data For Gene Therapy In ADA-SCID

25 May 16 09:28

BROKER RATINGS SUMMARY: Shore Says Buy Shire, Hold GlaxoSmithKline

25 May 16 08:34

Britain's Serious Fraud Office re-examines funding model

By Kirstin Ridley LONDON, May 24 (Reuters) - The Serious Fraud Office (SFO), Britain's leading fraud and corruption investigator and prosecutor, said on Tuesday it was re-examining a funding model that has been criticised for risking weakening investigations and delaying cases. So-cal

24 May 16 17:13

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.